GSK plc
GSK
#232
Rank
A$146.60 B
Marketcap
A$73.14
Share price
-2.18%
Change (1 day)
0.53%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): A$4.17

According to GSK plc's latest financial reports the company's current EPS (TTM) is A$4.27. In 2025 the company made an earnings per share (EPS) of A$5.59 an increase over its 2024 EPS that were of A$2.36.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$4.17-25.33%
2025A$5.59136.36%
2024A$2.36-47.35%
2023A$4.49-64.2%
2022A$12.55182.29%
2021A$4.44-18.07%
2020A$5.4222.34%
2019A$4.4323.9%
2018A$3.58140.61%
2017A$1.4964.45%
2016A$0.90-90.61%
2015A$9.63178.12%
2014A$3.46-48.11%
2013A$6.6722.68%
2012A$5.44-11.31%
2011A$6.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.79 82.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.05-75.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.94-31.17%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$1.47-65.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.56 147.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.67-84.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
A-$0.47-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA